A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study).
Eur J Cancer
; 125: 31-37, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31835236
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Sulfonamides
/
Antineoplastic Combined Chemotherapy Protocols
/
Deoxycytidine
/
Leiomyosarcoma
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Cancer
Year:
2020
Document type:
Article